KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to $27.5 million.

  • Charles River Laboratories International's Net Cash Flow rose 1998.08% to $27.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.9 million, marking a year-over-year decrease of 11037.11%. This contributed to the annual value of -$61.4 million for FY2024, which is 27442.51% down from last year.
  • Per Charles River Laboratories International's latest filing, its Net Cash Flow stood at $27.5 million for Q3 2025, which was up 1998.08% from -$59.7 million recorded in Q2 2025.
  • Over the past 5 years, Charles River Laboratories International's Net Cash Flow peaked at $227.0 million during Q1 2021, and registered a low of -$249.6 million during Q2 2021.
  • Its 5-year average for Net Cash Flow is -$3.8 million, with a median of $49000.0 in 2023.
  • In the last 5 years, Charles River Laboratories International's Net Cash Flow surged by 31129.08% in 2021 and then crashed by 31477142.86% in 2024.
  • Quarter analysis of 5 years shows Charles River Laboratories International's Net Cash Flow stood at $19.6 million in 2021, then skyrocketed by 54.06% to $30.2 million in 2022, then soared by 251.64% to $106.1 million in 2023, then tumbled by 93.05% to $7.4 million in 2024, then skyrocketed by 272.87% to $27.5 million in 2025.
  • Its last three reported values are $27.5 million in Q3 2025, -$59.7 million for Q2 2025, and $20.9 million during Q1 2025.